Progestin‐associated meningiomas can be managed by discontinuing treatment

Takeaway

  • The number of progestin‐associated meningiomas in women has increased over the past two decades; discontinuing treatment is a safe and effective way to treat these tumors.

Why this matters

    These novel findings highlight the need for more standardized data collection of essential information regarding progestin treatments. Magnetic resonance imaging should be readily accessible to women using progestin to facilitate screening, rapid identification, and management of meningiomas.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.